Imexpharm Corporation (HOSE:IMP)
Vietnam
· Delayed Price · Currency is VND 51,100
-100 (-0.20%)
At close: Jun 26, 2025
Imexpharm Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 25, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 7,916,061 | 7,238,421 | 3,962,167 | 4,013,628 | 5,187,048 | 3,753,609 | Upgrade
| |
Market Cap Growth | 42.66% | 82.69% | -1.28% | -22.62% | 38.19% | 58.34% | Upgrade
|
Enterprise Value | 7,849,685 | 7,072,195 | 3,840,834 | 3,828,514 | 5,172,206 | 3,829,402 | Upgrade
|
Last Close Price | 51400.00 | 46549.81 | 25168.19 | 25127.46 | 31748.83 | 22544.27 | Upgrade
|
PE Ratio | 25.60 | 24.33 | 14.26 | 21.83 | 29.89 | 20.89 | Upgrade
|
Forward PE | - | 20.30 | 11.68 | 19.00 | 21.00 | 17.00 | Upgrade
|
PS Ratio | 3.43 | 3.28 | 1.99 | 2.44 | 4.10 | 2.74 | Upgrade
|
PB Ratio | 3.52 | 3.32 | 1.90 | 2.12 | 2.89 | 2.17 | Upgrade
|
P/TBV Ratio | 3.64 | 3.43 | 1.97 | 2.20 | 3.01 | 2.27 | Upgrade
|
P/FCF Ratio | - | 60.57 | - | 14.37 | 28.50 | - | Upgrade
|
P/OCF Ratio | 77.19 | 33.47 | - | 10.60 | 22.08 | 51.31 | Upgrade
|
EV/Sales Ratio | 3.40 | 3.21 | 1.93 | 2.33 | 4.08 | 2.80 | Upgrade
|
EV/EBITDA Ratio | 14.63 | 13.62 | 8.28 | 10.73 | 17.56 | 12.12 | Upgrade
|
EV/EBIT Ratio | 18.15 | 17.04 | 10.08 | 12.91 | 22.10 | 14.59 | Upgrade
|
EV/FCF Ratio | -5531.42 | 59.18 | - | 13.71 | 28.42 | - | Upgrade
|
Debt / Equity Ratio | 0.17 | 0.04 | 0.02 | 0.05 | 0.15 | 0.08 | Upgrade
|
Debt / EBITDA Ratio | 0.73 | 0.17 | 0.11 | 0.27 | 0.90 | 0.41 | Upgrade
|
Debt / FCF Ratio | - | 0.72 | - | 0.34 | 1.45 | - | Upgrade
|
Asset Turnover | 0.86 | 0.90 | 0.85 | 0.72 | 0.58 | 0.69 | Upgrade
|
Inventory Turnover | 1.79 | 1.68 | 1.78 | 1.78 | 1.46 | 1.94 | Upgrade
|
Quick Ratio | 2.11 | 2.00 | 1.49 | 1.62 | 1.56 | 1.43 | Upgrade
|
Current Ratio | 4.49 | 4.38 | 3.92 | 2.89 | 2.88 | 2.83 | Upgrade
|
Return on Equity (ROE) | 15.17% | 15.04% | 15.06% | 12.12% | 10.73% | 12.75% | Upgrade
|
Return on Assets (ROA) | 10.04% | 10.60% | 10.20% | 8.11% | 6.66% | 8.32% | Upgrade
|
Return on Capital (ROIC) | 11.03% | 11.79% | 11.55% | 9.16% | 7.46% | 9.49% | Upgrade
|
Return on Capital Employed (ROCE) | 17.30% | 19.00% | 18.30% | 15.70% | 12.40% | 15.00% | Upgrade
|
Earnings Yield | 3.91% | 4.43% | 7.56% | 5.57% | 3.65% | 5.59% | Upgrade
|
FCF Yield | -0.02% | 1.65% | -2.60% | 6.96% | 3.51% | -0.44% | Upgrade
|
Dividend Yield | 0.97% | 1.07% | 1.81% | 1.72% | 2.04% | 2.88% | Upgrade
|
Payout Ratio | 21.00% | 21.82% | 22.26% | 44.74% | 52.89% | 23.55% | Upgrade
|
Buyback Yield / Dilution | 1.93% | - | 0.00% | 0.00% | -2.92% | -0.86% | Upgrade
|
Total Shareholder Return | 2.91% | 1.07% | 1.81% | 1.72% | -0.87% | 2.02% | Upgrade
|
Updated Jan 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.